May 2023

ImpediMed

ImpediMed

Joint Lead Manager (Placement)

Canaccord Genuity Acts as Joint Lead Manager to ImpediMed on its A$20m Placement

More Like This

US$92m

December 2024

Candel Therapeutics

Joint Bookrunner (CMPO)
December 2024

Neuronetics

Financial Advisor to Neuronetics on its Merger with Greenbrook TMS
November 2024

UCB

Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma

View all Healthcare transactions